| Course | PSY FPX 6010 Human Prenatal Development |
|---|---|
| Assessment | Assessment 2 |
| Paper type | Teratogen research review |
| Length | About 1,090 words, 5 pages |
| Format | APA 7 student paper |
| School | Capella University |
| Program | MS in Psychology |
| Updated | September 2026 |
Free sample paper for PSY FPX 6010 Assessment 2
Prenatal Acetaminophen and Childhood ADHD and Autism: A Teratogen Research Review That Specifies the Exposure, Puts Mechanism Before Outcomes, Names Each Design, Treats Confounding as Central, and Gives Risk With Its Base Rate
Student Name
Capella University
PSY FPX 6010: Human Prenatal Development
Instructor Name
Month Day, Year
The Exposure Specified Before Anything Else
The exposure is acetaminophen, also called paracetamol, the medicine most commonly used for pain and fever during pregnancy. Specifying the exposure means stating what counts as exposed. Studies have defined exposure as any use during pregnancy, use in a particular trimester, use for more than a certain number of weeks, or use at higher cumulative doses, and they have measured it by maternal report during pregnancy, by maternal recall afterward, or through prescription and antenatal records. Because acetaminophen is sold without a prescription, records capture only part of use. These differences matter: a study that finds an association with prolonged use does not show an association with a few doses, and a study that relies on recall years later may misclassify exposure.
Mechanism Ahead of Outcomes
A plausible mechanism makes an association worth taking seriously. The mechanisms proposed for acetaminophen include effects on hormone signaling during fetal development and oxidative stress in developing brain tissue. Liew et al. (2014) cited evidence that acetaminophen may act as a hormone disruptor as part of their rationale. These mechanisms come mainly from laboratory and animal studies and have not been demonstrated in human fetal development. A mechanism also cuts both ways in interpretation: if acetaminophen acted through hormone disruption, one would expect effects to depend on timing and dose in a consistent way, and a finding that does not show such a pattern would count against the mechanism. A plausible mechanism is therefore a reason to investigate, not evidence that the association is causal.
Designs Named With Every Finding
Cohort studies with self-reported exposure. Liew et al. (2014) followed 64,322 children in the Danish National Birth Cohort, in which mothers reported acetaminophen use in telephone interviews during pregnancy and after birth. More than half of mothers reported use. Children exposed prenatally had a higher risk of a hospital diagnosis of hyperkinetic disorder, a diagnosis closely related to ADHD, with a hazard ratio of 1.37, and of using ADHD medication, with a hazard ratio of 1.29. Associations were stronger with use in more than one trimester and with more frequent use, a dose-response pattern. National register study with sibling control. Ahlqvist et al. (2024) studied nearly 2.5 million children born in Sweden from 1995 to 2019, with acetaminophen use recorded prospectively in antenatal and prescription records; 7.5% were recorded as exposed. In the full population, exposure was associated with slightly higher risk of autism, with a hazard ratio of 1.05, and of ADHD, with a hazard ratio of 1.07. The study then compared full siblings, one exposed and one not, born to the same mother. In these sibling comparisons, the associations disappeared: the hazard ratio was 0.98 for autism and 0.98 for ADHD, and there was no dose-response pattern. For intellectual disability, the pattern was the same: a slight association in the full population and none between siblings. When the same mother's exposed and unexposed children were compared, the association was gone.
Confounding Treated as the Central Problem
The central problem in this literature is confounding: factors that lead to acetaminophen use may themselves raise the risk of ADHD or autism. Mothers take acetaminophen for fever, infections, headaches, and chronic pain, and some of these conditions, or the factors behind them, may affect fetal development independently of the medicine. Parental characteristics also matter, since ADHD and autism are highly heritable, and parents with traits related to these conditions may differ in health behaviors, including medication use. Standard adjustment for measured factors cannot remove confounding by factors that were not measured, such as genetic predisposition. The sibling design addresses this directly: siblings share half their genes on average and the same mother, household, and many environmental factors, so comparing them removes much of the confounding that operates at the family level. The disappearance of the association in sibling comparisons in Ahlqvist et al. (2024) therefore suggests that the associations found in population-level studies, including Liew et al. (2014), may reflect family-level confounding rather than an effect of acetaminophen. The sibling design has its own limits. It cannot remove confounding by factors that differ between pregnancies, such as a fever in one pregnancy and not another, and siblings who differ in exposure may differ in other ways. Nonetheless, it is the strongest design available for this question, since a randomized trial of acetaminophen in pregnancy for this outcome would be neither practical nor ethical. The dose-response pattern in the Danish cohort, which is often cited as evidence of causation, is also consistent with confounding, since mothers who used acetaminophen more often may have been sicker, in more pain, or different in other ways from those who used it rarely.
Risk Given With Its Base Rate
Relative risks can sound alarming without base rates. In the Swedish population data, the crude risk of an ADHD diagnosis by age 10 was 2.46% among unexposed children and 2.87% among exposed children, and for autism 1.33% and 1.53% (Ahlqvist et al., 2024). Even taking the unadjusted difference at face value, about 4 more children per 1,000 exposed received an ADHD diagnosis by age 10. After sibling control, the estimated difference was essentially zero. For a parent, the practical scale of any possible risk is therefore small even before the sibling analysis is considered, and smaller still after it. The same holds for autism.
What Remains Uncertain
The evidence does not settle every question. The Swedish records capture acetaminophen use recorded by midwives and prescriptions, which may miss some over-the-counter use. Studies differ in how they define ADHD, from hospital diagnoses to parent-reported behavior. And the question of very prolonged or high-dose use has fewer data. The balance of evidence, weighted toward the design best able to address confounding, does not support a causal link between typical prenatal acetaminophen use and ADHD or autism.
Conclusion
Early cohort studies found associations between prenatal acetaminophen and ADHD-related outcomes, with hazard ratios around 1.3. A very large national study found much smaller associations in the full population and none when siblings were compared, pointing to confounding by family factors. Given that untreated fever and pain in pregnancy carry their own risks, the evidence as it stands supports careful, appropriate use rather than avoidance.
References
Ahlqvist, V. H., Sjöqvist, H., Dalman, C., Karlsson, H., Stephansson, O., Johansson, S., Magnusson, C., Gardner, R. M., & Lee, B. K. (2024). Acetaminophen use during pregnancy and children's risk of autism, ADHD, and intellectual disability. JAMA, 331(14), 1205-1214. https://doi.org/10.1001/jama.2024.3172
Liew, Z., Ritz, B., Rebordosa, C., Lee, P.-C., & Olsen, J. (2014). Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatrics, 168(4), 313-320. https://doi.org/10.1001/jamapediatrics.2013.4914
What the PSY FPX 6010 Assessment 2 instructions ask for
Assessment 2 in PSY FPX 6010 has you review research on a prenatal influence. You define the exposure precisely, explain any proposed biological mechanism, review studies of different designs, from animal research to large cohort and sibling studies, identify confounding factors, report risks in absolute as well as relative terms and reach a balanced conclusion. Mixed evidence should be reported as mixed. Research such as Ystrom and colleagues' Norwegian cohort work and the large Swedish sibling study by Ahlqvist and colleagues supports the review.
How the PSY-FPX6010 Assessment 2 example is put together
The review is arranged so that the evidence question never disappears. It opens by specifying the exposure precisely, which agent or condition, at what quantities, measured how in the studies under review, because vague exposures produce uninterpretable findings. A mechanism section explains how the influence is thought to act on developing tissue, which gives the outcomes a plausible pathway rather than a correlation alone. The evidence section groups studies by design, with the strongest first, and reports for each what was found, in whom, over what period, and how the analysis handled the variables that travel with the exposure. A timing and dose section examines whether effects differ by trimester and by amount, which is where prenatal reviews earn their marks. A limits section states what the assembled evidence cannot establish, and the conclusion sizes the risk honestly.
PSY FPX 6010 Assessment 2 scoring guide: what Distinguished looks like
Marks go to the specification of the exposure, the explanation of mechanism, the naming of study designs, the treatment of confounding, the reporting of risk and the conclusion. Exposure reaches Distinguished when specified by timing, dose and duration, such as use on more than twenty-eight days during pregnancy. The mechanism scores higher when explained before outcomes, for example possible effects on hormone signaling in the developing brain. Designs earn credit when named for every study, distinguishing animal work, cohort studies and sibling comparisons. Confounding should sit at the center of the review, since the fevers and infections that lead mothers to take the medicine may themselves affect the fetus. Risk should be reported with base rates, so a relative increase is shown alongside how common ADHD is in the population. The conclusion should match the strongest designs. Distinguished reviews avoid both alarm and false reassurance.
Common PSY FPX 6010 Assessment 2 mistakes, and how to avoid them
Teratogen reviews often report that an exposure is linked to a condition without saying how large or how certain the link is. Another weakness is ignoring confounding by indication, the possibility that the reason for taking the medicine explains the association. Study designs are not named, so a small animal study and a large sibling comparison appear equally persuasive. Relative risks appear without base rates, making small absolute risks sound frightening. Sibling-comparison studies, which control for shared family factors, are left out. The conclusion is either alarmist or dismissive. Media coverage is cited in place of research. Ordering studies by design strength and reporting the absolute risk for each keeps the review balanced and prepares the translation piece in Assessment 3.
Get a PSY FPX 6010 Assessment 2 example written to your instructions
Forward the Assessment 2 documents from your PSY FPX 6010 section, the instructions, the scoring guide and the influence your courseroom assigned. The review is built around that factor rather than a default one, and it lands inside 24-48h at no cost the first time. Bring your own exposure and sources to the paper you submit. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.
More PSY FPX 6010 papers and MS in Psychology samples
- PSY FPX 6010 Assessment 1: Developmental Timeline Analysis
- PSY FPX 6010 Assessment 3: Professional Translation Piece
- PSY FPX 6015 Assessment 2: Case Conceptualization
- PSY FPX 5201 Assessment 2: Integrative Literature Review
- PSY FPX 6020 Assessment 2: Systems Analysis
- PSY FPX 5140 Assessment 2: Program Evaluation Design
PSY FPX 6010 Assessment 2 questions, answered
Can I choose an influence outside the usual substances?
Often permitted, and the less obvious choice tends to make a stronger paper. Maternal stress, nutrition, infection, environmental contaminants and certain medications all have real literatures with the same evidential problems, and less familiar material forces you to read rather than recall. The requirement is a research base substantial enough to weigh, so check that studies exist before committing to a topic.
How do I handle animal research in a human development paper?
Report it as what it is: evidence about mechanism in a controlled system, obtained where human experimentation is impossible, and separated by species differences that may matter. Animal models often carry the causal claim that human cohorts cannot, so they belong in the review, labeled clearly and never merged with human findings in the same sentence as though both showed the same thing.
What if the evidence on my influence is genuinely mixed?
Then the review reports the split and explains it, which is stronger work than manufacturing a verdict. Differences in exposure measurement, in the populations sampled and in how confounding was handled account for much of the disagreement in this literature, and tracing a conflict to its methodological source demonstrates exactly the appraisal skill the criteria are built to find.
Where can I find a free PSY FPX 6010 Assessment 2 sample paper?
This page presents the prenatal acetaminophen review, specifying the exposure, putting mechanism before outcomes, naming each design, treating confounding as central and giving risk with its base rate.
What if the evidence is mixed in PSY FPX 6010 Assessment 2?
Report it as mixed, explain why studies differ and give most weight to designs that best control confounding, such as sibling comparisons.